Improving Epinephrine Responses in Hypoglycemia Unawareness With Real-Time Continuous Glucose Monitoring in Adolescents With Type 1 Diabetes
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To determine whether real-time continuous glucose monitoring (CGM) with preset alarms at specific glucose levels would prove a useful tool to achieve avoidance of hypoglycemia and improve the counterregulatory response to hypoglycemia in adolescents with type 1 diabetes with hypoglycemia unawareness. RESEARCH DESIGN AND METHODS: Adolescents with type 1 diabetes with hypoglycemia unawareness underwent hyperinsulinemic hypoglycemic clamp studies at baseline to determine their counterregulatory hormone responses to hypoglycemia. Subjects were then randomized to either standard therapy or real-time CGM for 4 weeks. The clamp study was then repeated. RESULTS: The epinephrine response during hypoglycemia after the intervention was greater in the CGM group than in the standard therapy group. CONCLUSIONS: A greater epinephrine response during hypoglycemia suggests that real-time CGM is a useful clinical tool to improve hypoglycemia unawareness in adolescents with type 1 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“With the low-glucose alarms set at 108 mg/dL, 4 weeks of real-time CGM use restored the epinephrine response and improved adrenergic symptoms during a hyperinsulinemic hypoglycemic clamp in a small group of adolescents with type 1 diabetes and hypoglycemic unawareness (122).”
From Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society (2013) · cites this paper as [122]
Experimental — accuracy not yet measuredIn the citing paper
“With the low-glucose alarms set at 108 mg/dL, 4 weeks of real-time CGM use restored the epinephrine response and improved adrenergic symptoms during a hyperinsulinemic hypoglycemic clamp in a small group of adolescents with type 1 diabetes and hypoglycemic unawareness (122).”
From Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society (2013) · cites this paper as [122]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hypoglycaemia: the limiting factor in the glycaemic management of type I and type II diabetes.
Cryer, P. (2002) · Diabetologia · doi:10.1007/s00125-002-0822-9 · Cited by 794 · cited 1×
“ypoglycemia unawareness is defined as the onset of neuroglycopenia before autonomic activation (1).”
BackgroundClarke, W. L., Cox, D. J., Gonder-Frederick, L. A., Julian, D., Schlundt, D., & Polonsky, W. (1995) · Diabetes Care · doi:10.2337/diacare.18.4.517 · Cited by 651 · cited 1×
“Hypoglycemia unawareness score was determined by the use of modified Clarke’s questionnaire (8).”
MethodHeller, S. R., & Cryer, P. E. (1991) · Diabetes · doi:10.2337/diab.40.2.223 · Cited by 531
Dagogo-Jack, S. E., Craft, S., & Cryer, P. E. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116302 · Cited by 471 · cited 1×
“Both defective counterregulatory responses and hypoglycemia unawareness constitute the hypoglycemia-associated autonomic failure (HAAF) associated with recurrent iatrogenic hypoglycemia (2-4).”
BackgroundRestoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes.
Cranston, I., Lomas, J., Amiel, S. A., Maran, A., & Macdonald, I. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91336-6 · Cited by 430 · cited 1×
“attenuated epinephrine component of defective counterregulation in affected patients (5-7).”
BackgroundMechanisms of Hypoglycemia-Associated Autonomic Failure and Its Component Syndromes in Diabetes
Cryer, P. E. (2005) · Diabetes · doi:10.2337/diabetes.54.12.3592 · Cited by 401
Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM.
Dagogo-Jack, S., Rattarasarn, C., & Cryer, P. E. (1994) · Diabetes · doi:10.2337/diab.43.12.1426 · Cited by 328
Fanelli, C., Pampanelli, S., Epifano, L., Rambotti, A. M., Di Vincenzo, A., Modarelli, F., Ciofetta, M., Lepore, M., Annibale, B., Torlone, E., et al. (1994) · Diabetologia · doi:10.1007/bf00399801 · Cited by 212 · cited 1×
“attenuated epinephrine component of defective counterregulation in affected patients (5-7).”
BackgroundAssessment and management of hypoglycemia in children and adolescents with diabetes
Clarke, W., Jones, T., Rewers, A., Dunger, D., & Klingensmith, G. J. (2008) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2008.00405.x · Cited by 189 · cited 1×
“the use of modified Clarke’s questionnaire (8).”
Self-citationAn Evaluation of Methods of Assessing Impaired Awareness of Hypoglycemia in Type 1 Diabetes
Geddes, J., Wright, R. J., Zammitt, N. N., Deary, I. J., & Frier, B. M. (2007) · Diabetes Care · doi:10.2337/dc06-2556 · Cited by 120
Cited by
Seaquist, E. R., Anderson, J., Childs, B., Cryer, P., Dagogo-Jack, S., Fish, L., Heller, S. R., Rodriguez, H., Rosenzweig, J., & Vigersky, R. (2013) · Diabetes Care · doi:10.2337/dc12-2480 · Cited by 1,389
“With the low-glucose alarms set at 108 mg/dL, 4 weeks of real-time CGM use restored the epinephrine response and improved adrenergic symptoms during a hyperinsulinemic hypoglycemic clamp in a small group of adolescents with type 1 diabetes and hypoglycemic unawareness (122).”
BackgroundSeaquist, E. R., Anderson, J., Childs, B., Cryer, P., Dagogo-Jack, S., Fish, L., Heller, S. R., Rodriguez, H., Rosenzweig, J., & Vigersky, R. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4127 · Cited by 412
Ly, T. T., Nicholas, J. A., Retterath, A., Lim, E. M., Davis, E. A., & Jones, T. W. (2013) · JAMA · doi:10.1001/jama.2013.277818 · Cited by 411
Self-citationAbraham, M. B., Jones, T. W., Naranjo, D., Karges, B., Oduwole, A., Tauschmann, M., & Maahs, D. M. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12698 · Cited by 226
Self-citationMechanisms of hypoglycemia unawareness and implications in diabetic patients
Martín-Timón, I. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i7.912 · Cited by 204
Assessment and management of hypoglycemia in children and adolescents with diabetes
Ly, T. T., Maahs, D. M., Rewers, A., Dunger, D., Oduwole, A., & Jones, T. W. (2014) · Pediatric Diabetes · doi:10.1111/pedi.12174 · Cited by 151
“Lack of hypoglycemic symptoms or hypoglycemia unawareness At what glucose level do you start to recognize hypoglycemia? What types of symptoms do you have? Consider increased monitoring of blood glucose levels Consider the use of real-time continuous glucose monitoring together with adjustment of glucose targets to av…”
Self-citationChoudhary, P., Ramasamy, S., Green, L., Gallen, G., Pender, S., Brackenridge, A., Amiel, S. A., & Pickup, J. C. (2013) · Diabetes Care · doi:10.2337/dc13-0939 · Cited by 160
“CONCLUSIONSdThis study describes the efficacy of CGM in reducing SH in patients with type 1 diabetes and IAH who had problematic hypoglycemia limiting daily activities despite structured education and (predominantly) treatment by CSII.”
BackgroundInfluentialGarg, S., Brazg, R. L., Bailey, T. S., Buckingham, B. A., Slover, R. H., Klonoff, D. C., Shin, J., Welsh, J. B., & Kaufman, F. R. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0292 · Cited by 138
Use of continuous glucose monitoring in children and adolescents *
Phillip, M., Danne, T., Shalitin, S., Buckingham, B. A., Laffel, L. M., Tamborlane, W. V., Battelino, T., & Participants, F. T. C. F. (2012) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2011.00849.x · Cited by 122
“(i) Patients who are doing frequent blood glucose testing (39); (ii) Patients who have severe hypoglycemic episodes (5); (iii) Patients who have hypoglycemic unawareness especially in young children (45); (iv) Patients who have nocturnal hypoglycemia (2, 46, 47); (v) Wide glucose excursions regardless of HbA1c levels…”
BackgroundContinuous Glucose Monitoring: Current Use and Future Directions
DeSalvo, D., & Buckingham, B. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0398-4 · Cited by 73
Lin, Y. K., Fisher, S. J., & Pop‐Busui, R. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13290 · Cited by 82
“In 2011, Ly et al.(130) carried out a small group randomized clinical trial study to evaluate whether the use of CGMs versus self-monitoring of blood glucose (SMBG) might improve epinephrine responses during hypoglycemic clamps in adolescents with type 1 diabetes and IAH (Table 2).”
BackgroundForlenza, G. P., Buckingham, B. A., Brown, S. A., Bode, B. W., Levy, C. J., Criego, A. B., Wadwa, R. P., Cobry, E. C., Slover, R. J., Messer, L. H., et al. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0546 · Cited by 78
Self-citationUpdate in the CNS Response to Hypoglycemia
McCrimmon, R. J. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1927 · Cited by 71
Hermanns, N., Heinemann, L., Freckmann, G., Waldenmaier, D., & Ehrmann, D. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296819831695 · Cited by 66
Severe Hypoglycemia: Is It Still a Threat for Children and Adolescents With Type 1 Diabetes?
Urakami, T. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00609 · Cited by 59
Restoration of Self-Awareness of Hypoglycemia in Adults With Long-Standing Type 1 Diabetes
Leelarathna, L., Little, S. A., Walkinshaw, E., Tan, H. K., Lubina-Solomon, A., Kumareswaran, K., Lane, A. P., Chadwick, T., Marshall, S. M., Speight, J., et al. (2013) · Diabetes Care · doi:10.2337/dc13-1004 · Cited by 56
“4 years) showed improved epinephrine responses after 4-week use of RT-CGM with preset low alarms at 6 mmol/L and advice to institute standard hypoglycemia treatment for blood glucose levels ,6 mmol/L (27).”
Litchman, M. L., & Allen, N. A. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817702657 · Cited by 50
Little, S. A., Leelarathna, L., Barendse, S. M., Walkinshaw, E., Tan, H. K., Lubina Solomon, A., de Zoysa, N., Rogers, H., Choudhary, P., Amiel, S. A., et al. (2014) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2492 · Cited by 48
“during a stepped hypoglycaemia clamp [128].”
Diabetes Technology and the Human Factor
Liberman, A., Buckingham, B. A., & Phillip, M. (2014) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.1513 · Cited by 46
Continuous Glucose Monitoring: Impact on Hypoglycemia
van Beers, C. A. J., & DeVries, J. H. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816653411 · Cited by 46
“In 2011, a hyperinsulinemic hypoglycemic clamp study by Ly et al showed that 4 weeks of CGM improved epinephrine responses in young T1DM patients with IAH, suggesting that IAH can be restored in adolescents by using CGM.70 This finding was not supported by a larger trial performed by the same study group.71 In 2014, L…”
BackgroundInfluentialLy, T. T., Brnabic, A. J. M., Eggleston, A., Kolivos, A., McBride, M. E., Schrover, R., & Jones, T. W. (2014) · Value in Health · doi:10.1016/j.jval.2014.05.008 · Cited by 43
“The use of RT-CGM with an insulin pump that features automated insulin suspension, that is, Low Glucose Suspend (LGS) pump, can further assist in avoiding hypoglycemia and improving epinephrine responses to hypoglycemia in patients with reduced hypoglycemic awareness [15].”
MethodSelf-citationLin, Y. K., Groat, D., Chan, O. T. M., Hung, M., Sharma, A. R., Varner, M. W., Gouripeddi, R., Facelli, J. C., & Fisher, S. J. (2019) · Journal of the Endocrine Society · doi:10.1210/jendso/bvz005 · Cited by 45
“One study assessed the use of hypoglycemia alarms with thresholds set at 108 mg/dL together with other hypoglycemia avoidance programs, and demonstrated an improvement in the epinephrine responses to hypoglycemia in an adolescent population [15].”
BackgroundBurckhardt, M., Abraham, M. B., Dart, J., Smith, G. J., Paramalingam, N., O’Dea, J. M., de Bock, M. I., Davis, E. A., & Jones, T. W. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0593 · Cited by 43
“7,14 Therefore, a total study period of 8 weeks was assumed to be sufficient to prevent a carry-over effect in either direction.”
Self-citationManagement of Hypoglycemia in Children and Adolescents with Type 1 Diabetes Mellitus
McGill, D. E., & Levitsky, L. L. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0771-1 · Cited by 39
Guasch, L., Sala, E., Ojeda, M. J., Valls, C., Bladé, C., Mulero, M., Blay, M., Ardèvol, A., García-Vallvé, S., & Pujadas, G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044972 · Cited by 33
“N Epinephrine (also known as adrenaline), which is found in Scoparia dulcis, has been reported to improve hypoglycemia [30].”
BackgroundDecision-Making in Diabetes Mellitus Type 1
Rustad, J. K., Musselman, D. L., Skyler, J. S., Matheson, D., Delamater, A. M., Kenyon, N. S., Cáceda, R., & Nemeroff, C. B. (2013) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.12010016 · Cited by 32
Clinical Use of Continuous Glucose Monitoring in Pediatrics
Lal, R., & Maahs, D. M. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0013 · Cited by 31
“23 Data strictly pertaining to CGM intervention in pediatric age patients are more limited and often amalgamated with older populations.”
Diabetes technology and the human factor
Liberman, A., Buckingham, B. A., & Phillip, M. (2011) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2010.02583.x · Cited by 24
Hypoglycemia Reduction and Accuracy of Continuous Glucose Monitoring
Kovatchev, B. P. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0144 · Cited by 24
“However, in a study of adolescents with hypoglycemia unawareness, epinephrine response was restored in most subjects with 4 weeks of CGM when the alarm threshold was set to 108 mg/dL.(10) It was also shown that real-time CGM reduced significantly severe hypoglycemia while improving hemoglobin A1c in patients with esta…”
BackgroundHypoglycaemia and its management in primary care setting
Ibrahim, M., Baker, J., Cahn, A., Eckel, R. H., El Sayed, N. A., Fischl, A. H., Gaede, P., Leslie, R. D., Pieralice, S., Tuccinardi, D., et al. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3332 · Cited by 21
“to improve the epinephrine response and induce higher adrenergic symptom scores to induced hypoglycaemia when compared to the control group when tested using hyperinsulinaemic hypoglycaemic clamps.(43) This data support the use of RT-CGM in patients with IAH,”
ResultAidenloo, N. S., Mehdizadeh, A., Valizadeh, N., Abbaszadeh, M. E., Qarequran, S., & Khalkhali, H. R. (2016) · Iranian Red Crescent Medical Journal · doi:10.5812/ircmj.31254 · Cited by 21
Demir, G., Özen, S., Çetin, H., Darcan, Ş., & Gökşen, D. (2019) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.galenos.2019.2019.0009 · Cited by 20
Urakami, T. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12030781 · Cited by 19
“[78] reported that rtCGM with the lowglucose alarm system improved epinephrine response, and rtCGM might be effective for”
BackgroundWhite, M. R., & Yates, D. T. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1250134 · Cited by 16
“Hypoxemia, and to a lesser extent hypoglycemia, stimulate secretion of the catecholamines norepinephrine and epinephrine from the fetal adrenal medulla (Gardner et al., 2002; Ly et al., 2011; Yates et al., 2012a).”
BackgroundContinuous glucose monitoring system: Is it really accurate, safe and clinically useful?
Sato, J., Hirose, T., & Watada, H. (2012) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2012.00197.x · Cited by 16
Insulin Pump Therapy With Automated Insulin Suspension: Toward Freedom From Nocturnal Hypoglycemia
Choudhary, P. (2013) · JAMA · doi:10.1001/jama.2013.278576 · Cited by 15
“In early nonrandomized “before and after” studies, this device was shown to reduce the duration of nocturnal hypoglycemia.9,10 The study by Ly et al11 reported in this issue of JAMA is the first randomized controlled trial to show a reduction in…”
BackgroundHybrid Closed Loop in Adults With Type 1 Diabetes and Severely Impaired Hypoglycemia Awareness
Lee, M. H., Gooley, J. L., Obeyesekere, V. R., Lu, J., Paldus, B., Hendrieckx, C., MacIsaac, R. J., McAuley, S. A., Speight, J., Vogrin, S., et al. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241245627 · Cited by 14
“51,52 Therefore, it may be difficult to discern if the improvements observed herein are attributable to use of CGM or the HCL system.”
Fang, F., Xiao, H., Li, C., Tian, H., Li, J., Li, Z., & Cheng, X. (2013) · The Aging Male · doi:10.3109/13685538.2013.818111 · Cited by 14
“When deficiency of glucagon and epinephrine responses to hypoglycemia were demonstrated [17,18], especially in elderly patients with type 2 diabetes, risk of nocturnal hypoglycemia was markedly increased.”
BackgroundImpaired Awareness of Hypoglycaemia
Frier, B. M. (2013) · Wiley eBooks · doi:10.1002/9781118695432.ch6 · Cited by 14
van Beers, C. A. J., Kleijer, S. J., Serné, E. H., Geelhoed-Duijvestijn, P. H. L. M., Snoek, F. J., Kramer, M. H. H., & Diamant, M. (2015) · BMC Endocrine Disorders · doi:10.1186/s12902-015-0040-3 · Cited by 13
“showed that 4 weeks of RT-CGM improved epinephrine responses in young T1DM patients with IAH, suggesting that IAH can be restored in adolescents by using RT-CGM [81].”
MethodDPP-IV, An Important Target for Antidiabetic Functional Food Design
Ojeda, M. J., Cereto‐Massagué, A., Valls, C., & Pujadas, G. (2014) · Springer eBooks · doi:10.1007/978-3-319-10226-9_7 · Cited by 12
Adolescence and Emerging Adulthood
Chen, C. W., & Laffel, L. M. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch70 · Cited by 12
Ikeda, T., Tani, N., Oritani, S., Shida, A., Aoki, Y., Morioka, F., & Ishikawa, T. (2018) · Case Reports in Medicine · doi:10.1155/2018/5864658 · Cited by 11
“However, it is easy to overlook hypoglycemia in patients with type 1 diabetes who fall into a comatose state with no “alarm reaction” produced by adrenaline in response to hypoglycemia [17].”
BackgroundRecent Advances in the Prevention of Hypoglycemia in Type 1 Diabetes
Realsen, J., & Chase, H. P. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0150 · Cited by 10
“A recent study in youth 59 demonstrated that CGM can be an effective tool for reducing hypoglycemia frequency and thus helping to reverse HUN.”
Continuous Glucose Monitoring in Children and Adolescents
Slover, R. H. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0303-6 · Cited by 10
Long-term effects of islet transplantation
Holmes-Walker, D. J., & Kay, T. (2016) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000355 · Cited by 9
“When patients with hypoglycemic unawareness and more than one severe hypoglycemic episode in the last 12 months were studied for 4 weeks on a sensor augmented pump with low glucose suspend [15], there was a six-fold increase in epinephrine response to hypoglycemia compared with standard therapy but no change in glucag…”
Resultde Adana, M. R., Dominguez-Lopez, M.-E., Machado, A., Colomo, N., Ortiz, M. T. A., & C-Soriguer, F. (2011) · Avances en Diabetología · doi:10.1016/j.avdiab.2011.11.003 · Cited by 9
Treatment Challenges for the Young Patient with Type 1 Diabetes
Youssef, J. E., & Ward, W. K. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0148 · Cited by 9
The impact of technology on impaired awareness of hypoglycaemia in type 1 diabetes
Berry, S. A., Goodman, I., Heller, S. R., & Iqbal, A. (2025) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188251346260 · Cited by 8
“Ly et al. 52 compared six participants with T1D who had received rtCGM versus five participants who had received standard care.”
Aspectos clínicos y diagnósticos de la diabetes infantil
Louvigné, M., Decrequy, A., Donzeau, A., Bouhours‐Nouet, N., & Coutant, R. (2018) · EMC - Pediatría · doi:10.1016/s1245-1789(17)88072-0 · Cited by 8
Diabetes technology and the human factor
Liberman, A., Buckingham, B. A., & Phillip, M. (2012) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2011.02858.x · Cited by 7
Closed-loop insulin delivery in adults with type 1 diabetes
Kumareswaran, K. (2012) · Apollo (University of Cambridge) · doi:10.17863/cam.16644 · Cited by 7
“[29] Counter-regulatory responses to hypoglycaemia were evaluated in 11 adolescents with hypoglycaemia unawareness during hypoglycaemic clamp studies performed at baseline and four weeks after real-time CGM versus SMBG.[30] CGM resulted in an improvement in epinephrine responses as well as perceived adrenergic symptom…”
Ray, M. K., McMichael, A., Rivera-Santana, M. V., Noel, J., & Hershey, T. G. (2021) · JMIR Diabetes · doi:10.2196/27027 · Cited by 6
“CGM use has also been shown to be related to improved treatment and outcomes, including more advanced and optimized treatment recommendations by physicians to improve glycemic outcomes [149,150], increased satisfaction with diabetes treatment [123,151], improved perceived awareness of or hormonal responses to hypoglyc…”
BackgroundEditorial: Continuous glucose monitoring: beyond diabetes management
Xiao, J. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1678600 · Cited by 6
Recurrent severe hypoglycemia in Type 1 diabetes: potential for prevention?
Henriksen, M. M., Due-Andersen, R., Thorsteinsson, B., & Pedersen‐Bjergaard, U. (2014) · Diabetes Management · doi:10.2217/dmt.14.41 · Cited by 5
Islet cell transplantation: current status in the UK
Choudhary, P., PARROTT, N. R., Birtles, L., & Rutter, M. K. (2012) · Practical Diabetes · doi:10.1002/pdi.1707 · Cited by 5
Urbanová, J., Michalec, J., & Brož, J. (2021) · Vnitřní lékařství · doi:10.36290/vnl.2021.091 · Cited by 4
Managing hypoglycemia in children: what the clinician needs to know before advising parents
Ly, T. T., & Jones, T. W. (2012) · Diabetes Management · doi:10.2217/dmt.12.73 · Cited by 4
Self-citationA study of emergency visits for hypoglycemia cases
Takahashi, T., Ito, T., Takei, T., & Yagi, K. (2013) · Nihon Kyukyu Igakukai Zasshi Journal of Japanese Association for Acute Medicine · doi:10.3893/jjaam.24.391 · Cited by 4
Continuous Glucose Monitoring in 2011
Battelino, T., & Bode, B. W. (2012) · Wiley eBooks · doi:10.1002/9781118321508.ch2 · Cited by 4
Fredheim, S., Foli-Andersen, P. J., Lærkholm, G., Svensson, J., Juhl, C. B., Olsen, B. S., Pilgaard, K. A., & Johannesen, J. (2018) · Acta Paediatrica · doi:10.1111/apa.14310 · Cited by 4
Fanelli, C. G., Lucidi, P., Bolli, G. B., & Porcellati, F. (2018) · Endocrinology · doi:10.1007/978-3-319-44433-8_22 · Cited by 3
Identification of natural products as antidiabetic agents using computer-aided drug design methods
Guasch-Pamies, L. (2011) · TDX (Tesis Doctorals en Xarxa) · Cited by 3
Liu, Y., Guo, C., Li, X., Li, S., Huang, J., Zhao, L., Zhu, Y., Liu, X., Wang, B., Lin, R., et al. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1685969 · Cited by 2
7 th Annual Symposium on Self-Monitoring of Blood Glucose (SMBG), May 8–10, 2014, Helsinki, Finland
Parkin, C. G., Mlinac, A., & Hinzmann, R. (2014) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0239 · Cited by 2
“Ly et al.(39) conducted a randomized clamp study to determine whether use of real-time CGM with preset alarms at specific glucose levels would improve the counterregulatory response to hypoglycemia in adolescents with type 1 diabetes with hypoglycemia unawareness.”
BackgroundDiabetes Technology and the Human Factor
Liberman, A., Buckingham, B. A., & Phillip, M. (2012) · Wiley eBooks · doi:10.1002/9781118321508.ch12 · Cited by 2
Aspectos clínicos y diagnósticos de la diabetes infantil
Bouhours‐Nouet, N., & Coutant, R. (2011) · EMC - Pediatría · doi:10.1016/s1245-1789(11)71180-5 · Cited by 2
Shalaby, A., & Eliwa, K. A. A.-S. (2015) · Endocrinology & Metabolic Syndrome · doi:10.4172/2161-1017.1000159 · Cited by 2
Hermanns, N., Ehrmann, D., & Kulzer, B. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30146-9 · Cited by 2
Fanelli, C. G., Lucidi, P., Bolli, G. B., & Porcellati, F. (2019) · Endocrinology · doi:10.1007/978-3-319-27316-7_22-2 · Cited by 2
Fanelli, C. G., Lucidi, P., Bolli, G. B., & Porcellati, F. (2020) · Endocrinology · doi:10.1007/978-3-030-36694-0_22 · Cited by 2
Fanelli, C. G., Lucidi, P., Bolli, G. B., & Porcellati, F. (2018) · Endocrinology · doi:10.1007/978-3-319-27316-7_22-1 · Cited by 2
White, M. R. (2023) · Lincoln (University of Nebraska) · Cited by 2
Identification of natural products as antidiabetic agents using computer-aided drug design methods
Guasch Pàmies, L. (2011) · Rovira & Virgili repository · Cited by 2
Continuous glucose monitoring in 2011
Battelino, T., & Bode, B. W. (2012) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2011.02848.x · Cited by 1
Technology for Hypoglycaemia: CSII and CGM
Schopman, J. E., & DeVries, J. H. (2013) · Wiley eBooks · doi:10.1002/9781118695432.ch9 · Cited by 1
Predictors of change in hypoglycemia unawareness among patients with type 1 diabetes
Melnychuk, J., Wyne, K. L., & Dungan, K. M. (2022) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3582 · Cited by 1
“Retinopathy, N (%) 70 (23) 49 (19) 21 (45) 0.”
Sandoval, D. A., Lamos, E. M., Younk, L. M., Hedrington, M. S., & Davis, S. N. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.03833-2 · Cited by 1
Preventing severe hypoglycemia in children and adolescents with type 1 diabetes
Ly, T. T. (2013) · UWA Profiles and Research Repository (UWA)
Self-citationTrast, J., & Ramchandani, N. (2012) · US Endocrinology · doi:10.17925/use.2012.08.01.30
Czupryniak, L., Myśliwiec, M., Jarosz-Chobot, P. A., Cypryk, K., Klupa, T., Szadkowska, A., Wierusz‐Wysocka, B., Strojek, K., & Walczak, M. (2014) · Via Medica Journals
Hypoglycaemia in children and adults with type 1 diabetes: clinical implications
Graveling, A. J. (2015) · ERA
Clinical Studies on Efficacy of Continuous Glucose Monitoring
Cherubini, V. (2020) · Springer eBooks · doi:10.1007/978-3-030-42806-8_4
Improving Patient Care in Young People With Type 1 Diabetes Using Advances in Technology
Burckhardt, M. (2021) · UWA Profiles and Research Repository (UWA) · doi:10.26182/yy7z-8p80
Mesure en continu de la glycémie et hypoglycémies
(2011) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(11)70216-4
Lablanche, S., Reach, G., Guerci, B., Sola‐Gazagnes, A., Meyer, L., Hanaire, H. P., Riveline, J., & Joubert, M. (2024) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2024.07.004
Management of Acute and Recurrent Hypoglycaemia
McCrimmon, R. J. (2013) · Wiley eBooks · doi:10.1002/9781118695432.ch8
Metadata
- Authors
- Ly, T. T., Hewitt, J., Davey, R. J., Lim, E. M., Davis, E. A., & Jones, T. W.
- Affiliations
- Princess Margaret Hospital for Children (AU)
- The University of Western Australia (AU)
- Sir Charles Gairdner Hospital (AU)
- The Kids Research Institute Australia (AU)
- Corresponding author
- Ly, Trang T.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-10-07
- Volume
- 34
- Issue
- 1
- Pages
- 50-52
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3005473
- OpenAlex
- W2140628498
- Cited by
- 81
- References
- 10
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 3 · 2023: 2 · 2022: 1 · 2021: 3 · 2020: 6 · 2019: 5 · 2018: 6 · 2017: 2 · 2016: 4 · 2015: 5 · 2014: 7 · 2013: 15 · 2012: 13
- FWCI
- 8.21
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- UWA Profiles and Research Repository (University of Western Australia) (publishedVersion, other-oa)
- PubMed (publishedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- hypoglycemia unawareness, type 1 diabetes, adolescents, continuous glucose monitoring, epinephrine response, counterregulatory hormones, hyperinsulinemic hypoglycemic clamp, hypoglycemia prevention
- MeSH terms
- Adolescent, Blood Glucose, Child, Diabetes Mellitus, Type 1, Epinephrine, Humans, Hypoglycemia, Hypoglycemic Agents, Glucose Clamp Technique
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
